Repligen Reports Strong Q3 2024 with Revenue Growth

Repligen Reports Third Quarter 2024 Financial Results

Third quarter reported revenue of $155 million, an increase of 10% year-over-year CDMO revenue and orders both up ~20% year-over-year ...

Repligen Reports Strong Q3 2024 with Revenue Growth - Nasdaq

Repligen ( (RGEN) ) has provided an announcement.Repligen Corporation reported a robust third quarter of 2024, with a 10% increase in ...

Repligen Reports Third Quarter 2024 Financial Results

Third quarter reported revenue of $155 million, an increase of 10% year-over-year · CDMO revenue and orders both up ~20% year-over-year · Overall ...

Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights

Repligen Corp (RGEN) reports a robust 10% year-over-year revenue increase, while navigating headwinds in China and emerging biotech sectors.

Repligen Reports Strong Q3 2024 with Revenue Growth - TipRanks

Repligen ( ($RGEN) ) has provided an announcement. Repligen Corporation reported a robust third quarter of 2024, with a 10% increase in ...

Repligen's Strong Q3 and Strategic Moves - Markets Insider

Repligen reported its third quarter 2024 financial results with a notable 10% increase in revenue year-over-year, totaling $155 million. The ...

Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View

Repligen Corporation RGEN reported third-quarter 2024 adjusted earnings per share of 43 cents, which beat the Zacks Consensus Estimate of 34 ...

Repligen : Reports Third Quarter 2024 Financial Results Form 8 K

New modality, CDMO and equipment momentum. Reported record quarterly revenue for new modalities, a 20% increase year-over-year. CDMO and ...

Repligen Beats on EPS and Sales in Q3 | The Motley Fool

Repligen (RGEN 6.51%), a leader in bioprocessing technologies, released a strong third-quarter earnings report on Nov. 12.

Repligen Q3 Earnings Beat Expectations, Highlights Improving ...

... million in sales. The company raises 2024 EPS guidance and reports strong growth in CDMO and equipment.

Repligen Corporation Q3 2024 Earnings Summary - Intellectia.AI

The company's new modalities achieved record sales with a 20% year-over-year growth, a promising indicator of future growth potential. Equipment ...

Earnings call: Repligen reports robust growth and strategic ...

Repligen (NASDAQ:RGEN) Corporation (NASDAQ: RGEN) reported a strong financial performance in its Third Quarter 2024 Earnings Conference Call ...

Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View

Repligen Corporation ( RGEN Quick Quote RGEN - Free Report) reported third-quarter 2024 adjusted earnings per share of 43 cents, which beat ...

Repligen Corp Q3 2024 Earnings: Revenue Beats Estimates at $154.

Revenue: Reported at $154.87 million for Q3 2024, surpassing the analyst estimate of $153.23 million, reflecting a 10% year-over-year growth ...

Repligen Reports Third Quarter 2024 Financial Results - Quantisnow

New modality, CDMO and equipment momentum. Reported record quarterly revenue for new modalities, a 20% increase year-over-year. CDMO and ...

Repligen Reports Third Quarter 2024 Financial Results - Barchart.com

New modality, CDMO and equipment momentum. Reported record quarterly revenue for new modalities, a 20% increase year-over-year. CDMO and ...

Repligen's Robust Growth and Market Position Drive Buy Rating ...

Management's guidance for stable base business growth into 2024, and expectations of 10% organizational growth in 2025, further bolster this ...

Repligen Reports Third Quarter 2024 Financial Results

New modality, CDMO and equipment momentum. Reported record quarterly revenue for new modalities, a 20% increase year-over-year. CDMO and ...

Repligen: Q3 Earnings Snapshot - Barchart.com

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Repligen Corp. (RGEN) on Tuesday reported a loss of $653,000 in its third quarter.

Press Releases | Repligen

10/31/2024. 7:30 AM ET. Press Release. Repligen to Report Third Quarter 2024 Financial Results. 10/31/2024. Summary. Webcast and Conference Call to Be Held ...